First Quadrant’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

First Quadrant’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-18,700	Closed	-$60K	–	892
2016 Q1	$60K	Buy	+18,700	New	+$69.1K	﹤0.01%	680
2013 Q4	–	Sell	-9,700	Closed	-$53K	–	857
2013 Q3	$53K	Hold	9,700	–	–	﹤0.01%	675
2013 Q2	$39K	Buy	+9,700	New	+$45.5K	﹤0.01%	708

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

First Quadrant's BDSI Position: Q2 2016 in Review

First Quadrant sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2016, closing a stake of 18,700 shares — an estimated $60K sold.

First Quadrant first reported a position in BDSI in Q2 2013 and held it in 3 quarters. The position peaked at $60K in Q1 2016. 88 funds tracked by Wall St. Rank hold BDSI as of Q2 2016.

First Quadrant reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2016 after selling out during the quarter.
First Quadrant sold 18,700 BioDelivery Sciences International, Inc. shares in Q2 2016, an estimated $60K.
First Quadrant first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 3 quarters.
First Quadrant's BioDelivery Sciences International, Inc. position peaked at $60K in Q1 2016.
88 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2016.

Based on First Quadrant's 13F filing for Q2 2016, filed 19 Jul 2016.